Cargando…

BSL3 and BSL4 agents : proteomics, glycomics, and antigenicity /

Unique coverage of proteomic and glycomic approaches to better distinguish highly dangerous pathogens, as well as using these to explore novel treatment and prevention options. The editors and authors are either part of a specialized European network initiated to develop fast and reliable detection...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Štulík, Jiří
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Weinheim : Wiley-Blackwell, ©2011.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn759212293
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 111101s2011 gw a ob 001 0 eng d
040 |a UIU  |b eng  |e pn  |c UIU  |d E7B  |d OCLCO  |d CDX  |d OCLCQ  |d IDEBK  |d OCLCQ  |d COO  |d OCLCQ  |d EBLCP  |d MERUC  |d DEBSZ  |d N$T  |d OCLCQ  |d LOA  |d OCLCO  |d OCLCA  |d COCUF  |d MOR  |d ZCU  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d OCLCF  |d OCLCO  |d ICG  |d INT  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCA  |d OCLCQ  |d DKC  |d OCLCO  |d OCLCQ  |d UKAHL  |d UX1  |d OL$  |d OCLCQ  |d OCLCA  |d UKCRE  |d VLY  |d VHC  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCL 
019 |a 787842600  |a 843099557  |a 961497739  |a 962650490  |a 965994061  |a 988488507  |a 1065707547  |a 1153529085  |a 1162434840  |a 1290086706  |a 1303426416 
020 |a 9783527638192  |q (electronic bk.) 
020 |a 3527638199  |q (electronic bk.) 
020 |a 1283835355  |q (ebk) 
020 |a 9781283835350  |q (ebk) 
020 |a 9783527638215 
020 |a 3527638210 
020 |z 9783527327805  |q (hbk.) 
020 |z 3527327800  |q (hbk.) 
020 |a 3527638202 
020 |a 9783527638208 
029 1 |a AU@  |b 000053011007 
029 1 |a AU@  |b 000055807770 
029 1 |a DEBBG  |b BV041912543 
029 1 |a DEBBG  |b BV044160312 
029 1 |a DEBSZ  |b 431074240 
029 1 |a DEBSZ  |b 449277372 
029 1 |a NZ1  |b 14976525 
035 |a (OCoLC)759212293  |z (OCoLC)787842600  |z (OCoLC)843099557  |z (OCoLC)961497739  |z (OCoLC)962650490  |z (OCoLC)965994061  |z (OCoLC)988488507  |z (OCoLC)1065707547  |z (OCoLC)1153529085  |z (OCoLC)1162434840  |z (OCoLC)1290086706  |z (OCoLC)1303426416 
037 |a 414785  |b MIL 
050 4 |a QR175  |b .B75 2011eb 
060 4 |a 2011 L-537 
060 4 |a WC 200 
072 7 |a SCI  |x 008000  |2 bisacsh 
072 7 |a SCI  |x 045000  |2 bisacsh 
082 0 4 |a 579.165  |2 22 
049 |a UAMI 
245 0 0 |a BSL3 and BSL4 agents :  |b proteomics, glycomics, and antigenicity /  |c edited by Jiří Štulík [and others]. 
260 |a Weinheim :  |b Wiley-Blackwell,  |c ©2011. 
300 |a 1 online resource (xix, 236 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a Unique coverage of proteomic and glycomic approaches to better distinguish highly dangerous pathogens, as well as using these to explore novel treatment and prevention options. The editors and authors are either part of a specialized European network initiated to develop fast and reliable detection and therapy options, or are associated with the core military research complex of the United States. With its description of the methods, their advantages and limitations, as well as the principle outcomes, this is a must-have resource for all professionals dealing with BSL3 and/or BSL 4 agents. 
505 0 |a BSL3 and BSL4 Agents: Proteomics, Glycomics, and Antigenicity; Contents; Preface; List of Contributors; 1: Introduction: Application of Proteomic Technologies for the Analysis of Microbial Infections; 1.1 Introduction; 1.2 Search for New Factors of Virulence and Potential Diagnostic Markers; 1.3 Search for New Vaccine Candidates; 1.4 Analysis of Post-Translational Modifications of Bacterial Proteins and Protein-Protein Interactions; 1.5 Conclusions; References; Part One: Basic Proteomic Methods; 2: Separation of Proteins and Peptides; 2.1 Introduction; 2.1.1 Gel-Based Separation. 
505 8 |a 2.1.1.1 One-Dimensional Electrophoresis2.1.1.2 Two-Dimensional Electrophoresis; 2.1.1.3 Protein Staining and Image Analysis; 2.1.1.4 2-DE Limitations; 2.1.2 In Solution-"Gel Free" Proteomics; 2.1.3 Column Chromatography; 2.1.3.1 Size Exclusion Chromatography; 2.1.3.2 Reversed-Phase Liquid Chromatography; 2.1.3.3 Hydrophilic Interaction Liquid Chromatography; 2.1.3.4 Ion Exchanger Chromatography; 2.1.3.5 Affinity Chromatography; 2.1.3.6 Multidimensional Chromatography; 2.1.4 Liquid Phase IEF and Electrophoresis; 2.1.5 Alternative Separation Technologies; Acknowledgment; References. 
505 8 |a 3: Basic Mass Spectrometric Approaches3.1 Introduction; 3.2 Ionization; 3.2.1 Matrix-Assisted Laser Desorption/Ionization; 3.2.2 Electrospray Ionization; 3.3 Mass Analyzers; 3.3.1 Time of Flight; 3.3.2 Reflectron TOF; 3.3.3 Quadrupole and Ion Trap; 3.3.4 Fourier Transformation Ion Cyclotron; 3.3.5 Tandem Mass Analyzers; 3.3.6 Ion Detection; 3.4 Protein Identification; 3.4.1 Combination of 2-DE and MS; 3.4.2 Peptide Mass Fingerprinting; 3.4.3 Peptide Sequencing (PMF); 3.4.4 Shotgun Proteomics; 3.5 Conclusion; Acknowledgments; References; 4: Quantitative Mass Spectrometric Approaches. 
505 8 |a 4.1 Introduction4.1.1 Gel-Based Quantitative Proteomic Methods; 4.1.2 Shotgun Quantitative Proteomic Methods; 4.1.3 Labeling Methods; 4.1.3.1 Metabolic Incorporation of Stable Isotopes; 4.1.3.2 Enzymatic Incorporation of Stable Isotopes; 4.1.3.3 Chemical Incorporation of Stable Isotopes; 4.2 iTRAQ Analysis of Bacterial Pathogens; 4.2.1 Bacterial Cell Disruption and Protein Extraction; 4.2.2 Determination of Protein Concentration; 4.2.3 Protein Digestion; 4.2.4 Peptide Labeling with iTRAQ Tags; 4.2.5 Protocol for iTRAQ Analysis of Bacterial Proteins; References. 
505 8 |a 5: BN-PAGE of Microbial Protein Complexes5.1 Introduction; 5.2 Methods for Studying Protein-Protein Interactions; 5.3 Blue Native Polyacrylamide Gel Electophoresis; 5.3.1 Sample Preparation; 5.3.1.1 Non-Denaturing Conditions; 5.3.1.2 Selection of Detergent and Its Optimal Concentration; 5.3.1.3 Membrane and Cytosolic Fraction Separation; 5.3.2 1D BN-PAGE; 5.3.3 2D BN/SDS-PAGE; 5.4 Evaluation of BN-PAGE-Staining, MS, Western Blotting; 5.4.1 Staining; 5.4.1.1 Silver Staining; 5.4.1.2 Fluorescent Staining; 5.4.1.3 Coomassie Staining; 5.4.2 Mass Spectrometry; 5.4.3 Western Blotting. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Pathogenic microorganisms  |x Analysis. 
650 0 |a Proteomics. 
650 0 |a Glycomics. 
650 0 |a Antigens. 
650 0 |a Genomics. 
650 0 |a Diseases. 
650 0 |a Chemistry. 
650 0 |a Life sciences. 
650 0 |a Biology. 
650 0 |a Physical sciences. 
650 0 |a Bacterial diseases. 
650 0 |a Virus diseases. 
650 0 |a Biochemistry. 
650 0 |a Biological products. 
650 2 |a Biological Factors 
650 2 |a Bacterial Infections and Mycoses 
650 2 |a Genomics 
650 2 |a Carbohydrate Biochemistry 
650 2 |a Disease 
650 2 |a Chemistry 
650 2 |a Genetics 
650 2 |a Computational Biology 
650 2 |a Chemicals and Drugs 
650 2 |a Biological Science Disciplines 
650 2 |a Biology 
650 2 |a Natural Science Disciplines 
650 2 |a Disciplines and Occupations 
650 2 |a Antigens 
650 2 |a Glycomics 
650 2 |a Proteomics 
650 2 |a Bacterial Infections 
650 2 |a Virus Diseases 
650 2 |a Biochemistry 
650 1 2 |a Bacterial Infections  |x genetics 
650 2 2 |a Virus Diseases  |x genetics 
650 6 |a Micro-organismes pathogènes  |x Analyse. 
650 6 |a Protéomique. 
650 6 |a Glycomique. 
650 6 |a Antigènes. 
650 6 |a Produits biologiques. 
650 6 |a Génomique. 
650 6 |a Maladies. 
650 6 |a Chimie. 
650 6 |a Bio-informatique. 
650 6 |a Sciences de la vie. 
650 6 |a Biologie. 
650 6 |a Sciences physiques. 
650 6 |a Maladies bactériennes. 
650 6 |a Maladies à virus. 
650 6 |a Biochimie. 
650 7 |a chemistry.  |2 aat 
650 7 |a biological sciences.  |2 aat 
650 7 |a biology.  |2 aat 
650 7 |a physical sciences.  |2 aat 
650 7 |a biochemistry.  |2 aat 
650 7 |a SCIENCE  |x Life Sciences  |x Biology.  |2 bisacsh 
650 7 |a SCIENCE  |x Life Sciences  |x Microbiology.  |2 bisacsh 
650 7 |a Virus diseases  |2 fast 
650 7 |a Physical sciences  |2 fast 
650 7 |a Life sciences  |2 fast 
650 7 |a Genomics  |2 fast 
650 7 |a Diseases  |2 fast 
650 7 |a Chemistry  |2 fast 
650 7 |a Biology  |2 fast 
650 7 |a Biochemistry  |2 fast 
650 7 |a Bacterial diseases  |2 fast 
650 7 |a Antigens  |2 fast 
650 7 |a Glycomics  |2 fast 
650 7 |a Proteomics  |2 fast 
700 1 |a Štulík, Jiří. 
758 |i has work:  |a BSL3 and BSL4 agents (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGJjHCqb4mtyVcd6QTgTjK  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t BSL3 and BSL4 agents.  |d Weinheim : Wiley-Blackwell, ©2011  |z 9783527327805  |w (OCoLC)757032301 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=822728  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH23079808 
938 |a Askews and Holts Library Services  |b ASKH  |n AH21643918 
938 |a Coutts Information Services  |b COUT  |n 24299645 
938 |a EBL - Ebook Library  |b EBLB  |n EBL822728 
938 |a ebrary  |b EBRY  |n ebr10577683 
938 |a EBSCOhost  |b EBSC  |n 587890 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis24299645 
994 |a 92  |b IZTAP